MEDvidi is a technology company.
MEDvidi has raised $3.0M across 1 funding round.
MEDvidi has raised $3.0M in total across 1 funding round.
MEDvidi is a Silicon Valley-based telehealth technology company founded in 2019, specializing in accessible mental health services for conditions like ADHD, anxiety, depression, OCD, PTSD, and insomnia.[3][5] It builds a custom telemedicine platform with video/audio consultations, HIPAA-compliant CRM and EHR/EMR systems, AI-powered tools, a patient personal portal for booking and tracking, and integrations for payments and communication, serving US patients (primarily adults in 22+ states, expanding to all 50), board-certified providers, and clinics.[1][2][3][5] The platform solves key barriers in mental healthcare—long wait times (offering appointments within 24 hours), high costs (affordable cash-pay and insurance including Medicare/Medicaid), geographic limitations, and administrative burdens—while emphasizing personalized, on-demand care to make services efficient and stigma-free.[2][3][5] Growth has been strong: from seed funding of $2.8M in 2022, to 35,000-36,000 appointments by mid-2023, fourfold revenue increase, and goals of 70,000 monthly patients by 2026 alongside therapy expansions like CBT.[3][5]
MEDvidi was co-founded in April 2019 by Vasili Razhnou (CEO, with expertise in healthcare services and technology) and Alex Kulitski, starting with in-person mental health clinics in San Francisco and Miami.[3][5] The idea emerged from their combined backgrounds to deliver high-quality, affordable mental health support nationwide, pivoting to telemedicine amid the 2020 global health crisis when traditional care was disrupted.[1][5] A custom telehealth platform launched in 2020, featuring robust video/voice tools and CRM to reduce provider admin time; upgrades continued through 2021, backed by $2.8M seed from AltaIR Capital and TMT Investments in 2022.[1][3] Pivotal moments include platform enhancements (e.g., patient portal in 2021-2023), rapid scaling to 36,000 appointments by mid-2023, and CMO Dr. Laura Purdy joining to guide clinical services.[3][5]
MEDvidi rides the telehealth boom accelerated by the 2020 pandemic, tapping into surging demand for mental health services amid clinician shortages, remote access needs, and insurance expansions for virtual care.[1][2] Timing is ideal as US mental health crises persist—e.g., long waits and rural gaps—while market forces like broadband growth, AI integration, and payer shifts favor scalable platforms over in-person models.[2][3][6] It influences the ecosystem by advancing AI in telemedicine (e.g., data analytics for research, admin automation), enabling providers to serve more patients efficiently, and pushing geographic/service expansions that normalize on-demand care, potentially reshaping how startups and incumbents approach hybrid telehealth.[3][4][5]
MEDvidi is poised for explosive growth, targeting all 50 states by 2026, 70,000 monthly patients, in-person clinic reopenings, CBT launches, and wider condition coverage via AI enhancements and staff scaling.[3][5] Trends like AI-driven personalization, telehealth deregulation, and mental health destigmatization will propel it, evolving its role from virtual clinic to full tech enabler for providers. As CEO Razhnou notes, this positions MEDvidi to transform scalable, high-quality care—uniting patients and pros nationwide just as telehealth hit critical mass in 2020.[2][3]
MEDvidi has raised $3.0M in total across 1 funding round.
MEDvidi's investors include Gaingels, Tmt Investments.
MEDvidi has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Seed in September 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2022 | $3.0M Seed | Gaingels, Tmt Investments |